When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?

Overview

Journal Ann Vasc Dis

Specialty Cardiology & Vascular Diseases

Date 2018 Apr 24

PMID 29682105

Citations 11

Authors

Ali F AbuRahma

Affiliations

Soon will be listed here.

Abstract

Several meta-analyses and multicenter trials have shown that chronic limb ischemia did not occur for up to 5 years in 50%-70% of patients who underwent saphenous vein grafts, with limb salvage and perioperative mortality rates of >80% and 3%, respectively. However, open surgical bypass can have limitations, including postoperative morbidity/wound complications of 10%-20% and prolonged length of hospital stay and outpatient care. Several studies have analyzed clinical outcomes for patients with critical limb ischemia treated with endovascular therapies, but they have been mainly retrospective with significant heterogeneity or were single center. Only few randomized trials have compared surgical vs. endovascular therapy. These included the Bypass vs. Angioplasty in Severe Ischemia of the Leg (BASIL) trial, with no differences found in amputation-free or overall survival rates at 1 year; however, late outcomes favored the surgical group. The Bypass or Angioplasty in Severe Intermittent Claudication (BASIC) trial concluded that the 1-year patency rates were 82% and 43% for bypass and angioplasty, respectively. The BEST Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial is currently enrolling patients. This review analyzed studies comparing open vs. endovascular therapy in patients with femoropopliteal disease. (This is a review article based on the invited lecture of the 45th Annual Meeting of Japanese Society for Vascular Surgery.).

Citing Articles

Endovascular Transvenous versus Open Femoropopliteal Bypass.

Rumba R, Krievins D, Ezite N, Lacis A, Mouttet L, Vavere A Medicina (Kaunas). 2024; 60(5).

PMID: 38792960 PMC: 11123046. DOI: 10.3390/medicina60050777.

Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass.

Rumba R, Krievins D, Savlovskis J, Ezite N, Lacis A, Petrosina E Medicina (Kaunas). 2023; 59(3).

PMID: 36984464 PMC: 10059675. DOI: 10.3390/medicina59030462.

Strategies to counteract adverse remodeling of vascular graft: A 3D view of current graft innovations.

Tan W, Boodagh P, Selvakumar P, Keyser S Front Bioeng Biotechnol. 2023; 10:1097334.

PMID: 36704297 PMC: 9871289. DOI: 10.3389/fbioe.2022.1097334.

Nanoparticle coatings for controlled release of quercetin from an angioplasty balloon.

Craciun I, Astete C, Boldor D, Jennings M, Gorman J, Sabliov C PLoS One. 2022; 17(8):e0268307.

PMID: 36001584 PMC: 9401142. DOI: 10.1371/journal.pone.0268307.

Safety and feasibility study of non-invasive robot-assisted high-intensity focused ultrasound therapy for the treatment of atherosclerotic plaques in the femoral artery: protocol for a pilot study.

Simons M, Groen M, de Borst G, Leiner T, Doevendans P, Ebbini E BMJ Open. 2022; 12(5):e058418.

PMID: 35501090 PMC: 9062820. DOI: 10.1136/bmjopen-2021-058418.

References

Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A . Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014; 64(15):1568-76. DOI: 10.1016/j.jacc.2014.06.1198. View

Dake M, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M . Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011; 18(5):613-23. DOI: 10.1583/11-3560.1. View

Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A . Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2014; 131(5):495-502. PMC: 4323569. DOI: 10.1161/CIRCULATIONAHA.114.011004. View

Scheinert D, Laird Jr J, Schroder M, Steinkamp H, Balzer J, Biamino G . Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther. 2001; 8(2):156-66. DOI: 10.1177/152660280100800210. View

Singh N, Sidawy A, DeZee K, Neville R, Akbari C, Henderson W . Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg. 2008; 47(3):556-61. DOI: 10.1016/j.jvs.2007.10.059. View

McKinsey J, Goldstein L, Khan H, Graham A, Rezeyat C, Morrissey N . Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg. 2008; 248(4):519-28. DOI: 10.1097/SLA.0b013e318188e1de. View

Rooke T, Hirsch A, Misra S, Sidawy A, Beckman J, Findeiss L . 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice.... J Vasc Surg. 2011; 54(5):e32-58. DOI: 10.1016/j.jvs.2011.09.001. View

Mahoney E, Wang K, Keo H, Duval S, Smolderen K, Cohen D . Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes. 2010; 3(6):642-51. DOI: 10.1161/CIRCOUTCOMES.109.930735. View

Saxon R, Chervu A, Jones P, Bajwa T, Gable D, Soukas P . Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery.... J Vasc Interv Radiol. 2013; 24(2):165-73. DOI: 10.1016/j.jvir.2012.10.004. View

10.

Conte M, Geraghty P, Bradbury A, Hevelone N, Lipsitz S, Moneta G . Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009; 50(6):1462-73.e1-3. DOI: 10.1016/j.jvs.2009.09.044. View

11.

Andras A, Hansrani M, Stewart M, Stansby G . Intravascular brachytherapy for peripheral vascular disease. Cochrane Database Syst Rev. 2014; (1):CD003504. PMC: 6863108. DOI: 10.1002/14651858.CD003504.pub2. View

12.

Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J . Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther. 2014; 21(3):359-68. DOI: 10.1583/13-4630MR.1. View

13.

Romiti M, Albers M, Brochado-Neto F, Durazzo A, Pereira C, De Luccia N . Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008; 47(5):975-981. DOI: 10.1016/j.jvs.2008.01.005. View

14.

Dosluoglu H, Cherr G, Lall P, Harris L, Dryjski M . Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease. J Vasc Surg. 2008; 48(5):1166-74. DOI: 10.1016/j.jvs.2008.06.006. View

15.

Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M . Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study. Circulation. 2000; 102(22):2694-9. DOI: 10.1161/01.cir.102.22.2694. View

16.

van der Zaag E, Legemate D, Prins M, Reekers J, Jacobs M . Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg. 2004; 28(2):132-7. DOI: 10.1016/j.ejvs.2004.04.003. View

17.

Jahnke T, Mueller-Huelsbeck S, Charalambous N, Trentmann J, Jamili A, Huemme T . Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol. 2010; 21(2):186-94. DOI: 10.1016/j.jvir.2009.10.021. View

18.

Cioppa A, Stabile E, Popusoi G, Salemme L, Cota L, Pucciarelli A . Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revasc Med. 2012; 13(4):219-23. DOI: 10.1016/j.carrev.2012.04.007. View

19.

Conte M . Diabetic revascularization: endovascular versus open bypass--do we have the answer?. Semin Vasc Surg. 2012; 25(2):108-14. DOI: 10.1053/j.semvascsurg.2012.04.004. View

20.

Micari A, Cioppa A, Vadala G, Castriota F, Liso A, Marchese A . Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv. 2012; 5(3):331-8. DOI: 10.1016/j.jcin.2011.11.010. View